Vertex Pharmaceuticals Incorporated (VRTX), based in Boston, Massachusetts, is a prominent biotech firm specializing in the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston, Massachusetts-based company engages in developing and commercializing ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Vertex Pharmaceuticals is laying ...

Vertex Pharmaceuticals (NASDAQ:VRTX) has posted new data from a Phase 1/2/3 study for zimislecel (VX-880), its experimental therapy for type 1 diabetes, noting that the cell-based therapy achieved the ...

Dec 6 () - Vertex Pharmaceuticals said on Saturday its gene therapy helped children aged between 5 and 11 years with sickle ...

OF THE AREA MEDIAN INCOME. A GLOBAL BIOTECH COMPANY IS FOSTERING TALENT AMONG BOSTON PUBLIC SCHOOL KIDS. OUR ERIKA TARANTAL REPORTS ON THE PAID INTERNSHIP PROGRAM, GIVING STUDENTS THE OPPORTUNITY OF A ...

The RMR Group (Nasdaq: RMR) today announced on behalf of its managed joint venture that it has facilitated a $1.0 billion five-year, interest-only fixed rate mortgage financing with a weighted-average ...

New drugs like Journavx could represent a big step forward in disentangling the pain-medicine market from the use of opioids, which are still widely prescribed in the U.S. The U.S. Food and Drug ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will release earnings results for the first quarter, after the closing bell on Monday, May 5. Analysts expect the Boston, Massachusetts-based company ...